← Back to Screener
Quantum Cyber N.V. Ordinary Shares (QUCY)
Price$0.36
Favorite Metrics
Price vs S&P 500 (26W)-83.59%
Price vs S&P 500 (4W)-35.66%
Market Capitalization$4.55M
All Metrics
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)0.44%
Cash Flow / Share (Quarterly)$-1.23
Price vs S&P 500 (YTD)-75.72%
Gross Margin (TTM)72.58%
Net Profit Margin (TTM)-3018.31%
EPS (TTM)$-3.54
10-Day Avg Trading Volume1.49M
EPS Excl Extra (TTM)$-3.54
Revenue Growth (5Y)1.85%
EPS (Annual)$-2.70
ROI (Annual)-504.52%
Gross Margin (Annual)72.58%
Net Profit Margin (5Y Avg)-3074.28%
Cash / Share (Quarterly)$0.09
Revenue Growth QoQ (YoY)-32.92%
ROA (Last FY)-304.29%
Revenue Growth TTM (YoY)-39.92%
EBITD / Share (TTM)$-2.52
ROE (5Y Avg)-812.99%
Operating Margin (TTM)-3004.97%
Cash Flow / Share (Annual)$-1.23
P/B Ratio7.09x
Net Income / Employee (Annual)$-1,621,100
Net Interest Coverage (TTM)-51.58x
ROA (TTM)-214.27%
EPS Incl Extra (Annual)$-2.70
Current Ratio (Annual)0.50x
Quick Ratio (Quarterly)0.31x
3-Month Avg Trading Volume0.75M
52-Week Price Return-85.75%
Revenue / Employee (TTM)$53,700
P/S Ratio (Annual)8.47x
Asset Turnover (Annual)0.10x
52-Week High$2.64
Operating Margin (5Y Avg)-3017.67%
EPS Excl Extra (Annual)$-2.70
CapEx CAGR (5Y)153.71%
26-Week Price Return-75.45%
Quick Ratio (Annual)0.31x
13-Week Price Return-63.29%
Total Debt / Equity (Annual)4.01x
Current Ratio (Quarterly)0.50x
Revenue / Share Growth (5Y)19.81%
Asset Turnover (TTM)0.07x
Revenue / Employee (Annual)$53,700
Inventory Turnover (Annual)0.50x
Pretax Margin (Annual)-3018.31%
Cash / Share (Annual)$0.09
3-Month Return Std Dev120.81%
Gross Margin (5Y Avg)51.76%
Net Income / Employee (TTM)$-1,621,100
ROE (Last FY)-2526.61%
Net Interest Coverage (Annual)-51.58x
EPS Basic Excl Extra (Annual)$-2.70
Receivables Turnover (TTM)8.31x
Total Debt / Equity (Quarterly)4.01x
EPS Incl Extra (TTM)$-3.54
Receivables Turnover (Annual)8.31x
ROI (TTM)-421.58%
P/S Ratio (TTM)8.47x
Pretax Margin (5Y Avg)-3074.28%
Revenue / Share (Annual)$0.09
Price vs S&P 500 (52W)-116.29%
Year-to-Date Return-67.55%
5-Day Price Return-9.15%
EPS Normalized (Annual)$-2.70
ROA (5Y Avg)-177.06%
Net Profit Margin (Annual)-3018.31%
Month-to-Date Return-14.79%
EBITD / Share (Annual)$-2.55
Operating Margin (Annual)-3004.97%
LT Debt / Equity (Annual)0.32x
ROI (5Y Avg)-275.34%
LT Debt / Equity (Quarterly)0.32x
EPS Basic Excl Extra (TTM)$-3.54
Inventory Turnover (TTM)0.50x
Pretax Margin (TTM)-3018.31%
Price vs S&P 500 (13W)-72.15%
Beta-5.84x
Revenue / Share (TTM)$0.06
ROE (TTM)-1024.71%
52-Week Low$0.34
Analyst Recommendations
Dec 2025
Jan 2026
Feb 2026
Mar 2026
4.14
4.14
4.14
4.14
Industry Peers — Pharmaceuticals(311)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
QUCYQuantum Cyber N.V. Ordinary Shares | 8.47x | -39.92% | 72.58% | — | $0.36 |
| LLYEli Lilly & Co. | 12.36x | 47.44% | 82.83% | 27.59% | $948.45 |
| JNJJohnson & Johnson | 5.53x | 7.87% | 67.95% | 14.90% | $221.32 |
| ABBVABBVIE INC. | 5.83x | 8.57% | 71.62% | -2.88% | $201.55 |
| MRKMerck & Co., Inc. | 4.18x | 2.89% | 78.07% | 21.23% | $111.38 |
| NVONovo-Nordisk A/S | 4.25x | 6.43% | 80.98% | 20.66% | $46.07 |
| NVSNovartis AG | 4.74x | 5.77% | 75.41% | 15.26% | $146.03 |
| AZNAstraZeneca PLC | 4.66x | 9.93% | 81.42% | 21.88% | $182.85 |
| ABTAbbott Laboratories | 3.25x | 6.59% | 56.50% | 8.20% | $84.32 |
| PFEPfizer Inc. | 2.31x | 1.36% | 74.80% | -3.51% | $25.68 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | 2.48x | 4.41% | 52.77% | — | $35.73 |
About
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.